Qualité des données aux normes académiques

Publications: A Selection

• Ongoing

  Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU) (EffiDux)

  This clinical trial evaluates whether using the medidux app for symptom and vital sign monitoring after discharge from Acute Admission Units can reduce short-term readmissions and emergency visits in non-urgent patients. By comparing outcomes between app users and those receiving standard care, the study aims to determine if digital follow-up improves post-discharge management and reduces unnecessary healthcare utilization.

• Ongoing

  Swiss CanOn – Swiss Cannabis Oncology

  The Swiss CanOn registry uses the medidux platform to collect real-world data on the use of cannabis-based medicinal products in cancer care, combining physician-reported prescriptions with patient-reported outcomes via a smartphone app. This integrative approach aims to improve clinical understanding, support safer use, and inform future access to cannabinoid therapies.

• JMIR Cancer, 202410.2196/54178

  Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes

  Using the medidux app, patients treated with the HER2-targeted biosimilar Ogivri reported side effects and well-being outcomes equivalent to those of historical cohorts treated with Herceptin. Symptom burden was generally low and consistent across both groups. This real-world study shows that integrating an ePRO platform like medidux into care settings can reliably capture patient experiences, supporting informed treatment decisions and validating therapeutic equivalence in daily practice.

• JMIR Cancer, 202110.2196/26950

  Effect of Collaborative Review of Electronic Patient-Reported Outcomes for Shared Reporting in Breast Cancer Patients: Descriptive Comparative Study

  This comparative study of two Consilium app versions showed that prompting structured patient-physician reviews significantly increased the number and quality of electronic symptom entries. Patients using the newer version reported more frequently and found the app more helpful during consultations. These insights directly informed the development of medidux, reinforcing that integrating shared digital monitoring into routine care can improve the accuracy of ePROs and foster more meaningful clinical dialogue.

• Case Rep Oncol, 202010.1159/000507345

  Consilium Smartphone App for Real-World Electronically Captured Patient-Reported Outcome Monitoring in Cancer Patients Undergoing anti-PD-L1-Directed Treatment

  Six patients undergoing immunotherapy for advanced cancers used the Consilium app, medidux' predecessor, to log symptoms over three months, contributing over 1,200 real-time entries. Common symptoms like fatigue and shortness of breath were documented with detailed severity levels, triggering alerts without requiring unplanned visits. High satisfaction among patients and physicians highlighted how shared digital reporting via medidux can safely support outpatient care and improve the quality of clinical interactions.

• JMIR, 201610.2196/jmir.6414

  A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial

  In a randomized study of breast cancer patients undergoing chemotherapy, those who used Consilium (now medidux) to track symptoms and reviewed their data with a physician maintained stable daily functioning – unlike those without such review. Both groups using the app reported more adverse events than via traditional questionnaires provided only during planned visits, but supervised users made more precise, focused entries. These findings demonstrate medidux can support patient well-being and enhance symptom awareness during treatment.